AstraZeneca's Tagrisso plus chemotherapy appoved for lung ca

AstraZeneca's Tagrisso approved in the US for EGFRm non-small cell lung cancer with chemotherapy. FLAURA2 trial results show significant benefit.

Related Keywords

China , United States , Canada , Switzerland , Australia , Japan , American , Dave Fredrickson , Laurie Ambrose , American Cancer Society , Pathology Lab , Drug Administration , Dana Farber Cancer Institute , National Comprehensive Cancer Network , Lungevity Foundation , National Comprehensive Cancer Network Inc , Astrazeneca , Priority Review , New England Journal , Executive Vice President , Oncology Business Unit , Lung Cancer , Practical Guidelines , Project Orbis , Non Small Cell , Accessed February , What Is Lung , Cancer Biomarkers , Present Status , Clinical Oncology Provisional Opinion , Epidermal Growth Factor Receptor , Mutation Testing , Kinase Inhibitor , Practice Guidelines , Non Small Cell Lung Cancer Version ,